Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Effective acne management in PCOS includes hormone therapy, metformin, isotretinoin, weight loss, diet, exercise, and personalized treatment plans.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

Inositol was more effective than metformin in improving menstrual cycles and pregnancy rates in PCOS patients.

Doctors vary in how they initially test for PCOS, but most agree on using oral contraceptives and lifestyle changes as first treatments.

The contraceptive implant Implanon may be linked to hair loss, but the reported case of alopecia could be unrelated to the implant.

Both finasteride and metformin effectively treat PCOS by reducing hormone levels and insulin resistance.

Some women with acne have higher levels of free testosterone, which might suggest using hormonal treatments for acne.

Cyproterone acetate is effective for treating hirsutism, but some patients may feel worse on low-dose maintenance therapy.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Metformin lowers prolactin in women without PCOS but not in those with PCOS, where it reduces other hormones instead.

Women with Polycystic Ovary Syndrome (PCOS) have lower levels of a substance called DIAPH1 in their blood, which is linked to changes in sugar metabolism and insulin resistance.

Hormonal imbalances during menopause may significantly contribute to Frontal Fibrosing Alopecia.

Certain skin conditions in women are linked to higher risks of metabolic syndrome and type 2 diabetes due to hormone imbalances.

Testosterone helps human pancreatic cells increase insulin release.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

Women with PCOS may have a higher risk of respiratory and ear infections due to slower nasal mucociliary clearance.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

Estrogens are key for bone growth spurts in both boys and girls and affect growth into adulthood.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Female pattern hair loss does not significantly affect sexual dysfunction.

Higher androstenedione levels in women with PCOS are linked to more severe symptoms.

Higher insulin levels are linked to larger ovaries in women with idiopathic hirsutism.

Myo-inositol helps improve skin conditions and metabolic profiles in young women with PCOS.

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.

Women with epilepsy should be monitored for reproductive issues, which can be caused by epilepsy or its treatments, especially when using valproate.